Measuring changes in functional status among patients with schizophrenia: the link with cognitive impairment (Q36531343)

14 August 2017

1 reference

title

Measuring changes in functional status among patients with schizophrenia: the link with cognitive impairment (English)

1 reference

14 August 2017

0 references

cognitive dysfunction

1 reference

3

Scot Purdon

1 reference

14 August 2017

Louis S Matza

1

1 reference

14 August 2017

Robert Buchanan

2

1 reference

14 August 2017

Jessica Brewster-Jordan

4

1 reference

14 August 2017

Yang Zhao

5

1 reference

14 August 2017

Dennis A Revicki

6

1 reference

14 August 2017

language of work or name

English

0 references

publication date

7 July 2006

1 reference

14 August 2017

Schizophrenia Bulletin

1 reference

14 August 2017

32

1 reference

14 August 2017

4

1 reference

14 August 2017

666-678

1 reference

Recommendations for evaluating the validity of quality of life claims for labeling and promotion

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632260

Distinguishing separable domains of cognition in human and animal studies: what separations are optimal for targeting interventions? A summary of recommendations from breakout group 2 at the measurement and treatment research to improve cognition in

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632260

A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632260

Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632260

Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632260

Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632260

Cognitive functioning in schizophrenia: a consensus statement on its role in the definition and evaluation of effective treatments for the illness.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632260

Significance of functional status data for payment and quality

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632260

Cognitive function in schizophrenia. Deficits, functional consequences, and future treatment

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632260

Impact on cognition of the use of antipsychotics

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632260

Assessing meaningful change in quality of life over time: a users' guide for clinicians

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632260

Methods to explain the clinical significance of health status measures

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632260

A level-of-functioning self-report measure for consumers with severe mental illness

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632260

UCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632260

Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632260

Recommendations on health-related quality of life research to support labeling and promotional claims in the United States

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632260

Cognitive impairment in schizophrenia is the core of the disorder.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632260

Do specific neurocognitive deficits predict specific domains of community function in schizophrenia?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632260

Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632260

Schizophrenia and cognitive function

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632260

Cognitive dysfunction in schizophrenia and its importance to outcome: the place of atypical antipsychotics in treatment.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632260

Cognition, schizophrenia, and the atypical antipsychotic drugs

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632260

Cognitive functioning in schizophrenia: implications for psychiatric rehabilitation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632260

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632260

Clinical dementia rating training and reliability in multicenter studies: the Alzheimer's Disease Cooperative Study experience

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632260

What are the functional consequences of neurocognitive deficits in schizophrenia?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632260

The Clinical Dementia Rating (CDR): current version and scoring rules

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632260

Measurement of health status. Ascertaining the minimal clinically important difference

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632260

Quality of life in schizophrenia: a comparison of instruments. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632260

Neurocognitive and social functioning in schizophrenia.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632260

The cognitive efficacy of atypical antipsychotics in schizophrenia

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632260

Social skills at work. Deficits and predictors of improvement in schizophrenia

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632260

Assessment schedules for chronic psychiatric patients.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632260

The measurement of social behaviour in psychiatric patients: an assessment of the reliability and validity of the SBS schedule.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632260

Cognitive functions and psychopathological symptoms in early-onset schizophrenia.

28 June 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL004

Generalized cognitive deficits in schizophrenia: a study of first-episode patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL004

Cognitive functioning in stabilized first-episode psychosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL004

Cognitive functioning, cortisol release, and symptom severity in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL004

Measurement and Treatment Research to Improve Cognition in Schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL004

Atypical antipsychotics and cognition in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL004

Work rehabilitation in schizophrenia: does cognitive impairment limit improvement?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL004

Initial and final work performance in schizophrenia: cognitive and symptom predictors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL004

Cognitive and symptom predictors of work outcomes for clients with schizophrenia in supported employment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL004

Heterogeneity in functional status among older outpatients with schizophrenia: employment history, living situation, and driving

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL004

Demographic, clinical, and neurocognitive predictors of quality of life in schizophrenia patients receiving conventional neuroleptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL004

The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL004

The effects of neurocognitive remediation on executive processing in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL004

A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL004

Assessment of interpersonal problem-solving skills

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL004

A new clinical scale for the staging of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL004

An expanded version of the Multnomah Community Ability Scale: anchors and interview probes for the assessment of adults with serious mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL004

Detecting improvement in quality of life and symptomatology in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL004

A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL004

The functional consequences of memory impairments on initial work performance in people with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL004

Does ‘errorless learning’ compensate for neurocognitive impairments in the work rehabilitation of persons with schizophrenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL004

Reliable self-report of health service use by individuals with serious mental illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL004

Neurocognitive and social functioning in schizophrenia: a 2.5 year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL004

Relationship between cognitive and social dysfunction in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL004

Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimer's disease and normal aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL004

A measure of the stability of family activities: an initial examination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL004

The longitudinal relationship of clinical symptoms, cognitive functioning, and adaptive life in geriatric schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL004

Agreement between self-rated and clinically assessed symptoms in subjects with psychosis.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632260

The effectiveness of quetiapine versus conventional antipsychotics in improving cognitive and functional outcomes in standard treatment settings

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632260

Subjective and external assessments of quality of life in schizophrenia: relationship to insight.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632260

Neurocognitive deficit in schizophrenia: a quantitative review of the evidence.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632260

Alzheimer's Disease Assessment Scale: reliability and validity in a multicenter clinical trial.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632260

Is it possible to be schizophrenic yet neuropsychologically normal?

21 September 2018

2 references

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL004

21 January 2018

12 December 2020

Executive Function in Patients with Remitted Bipolar Disorder and Schizophrenia and Its Relationship with Functional Outcome

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL004

Quality of life in patients with schizophrenia—comparison of self-report and proxy assessments

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL004

Assessing the responsiveness of functional scales to clinical change: an analogy to diagnostic test performance

21 January 2018

1 reference

12 December 2020

Validation of clinical diagnostic criteria for Alzheimer's disease

1 reference

12 December 2020

Measuring outcome in schizophrenia: differences among the atypical antipsychotics. Collaborative Working Group on Clinical Trial Evaluations

1 reference

12 December 2020

Relationships between changes in symptom ratings, neurophysiological test performance and quality of life in schizophrenic patients treated with clozapine

1 reference

12 December 2020

Convergence of cognitive and adaptive decline in late-life schizophrenia

1 reference

12 December 2020

Social-Adaptive Functioning Evaluation (SAFE): a rating scale for geriatric psychiatric patients

1 reference

12 December 2020

The Course of Functional Decline in Geriatric Patients With Schizophrenia: Cognitive-Functional and Clinical Symptoms as Determinants of Change

1 reference

12 December 2020

The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome

1 reference

12 December 2020

Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia

1 reference

12 December 2020

Identifiers

DOI

10.1093/SCHBUL/SBL004

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

16829550

1 reference